Mutational analysis of SARS-CoV-2 variants of concern reveals key tradeoffs between receptor affinity and antibody escape.
Mutational analysis of SARS-CoV-2 variants of concern reveals key tradeoffs between receptor affinity and antibody escape.
复制标题
DOI:
10.1371/journal.pcbi.1010160
复制
发表时间:
2022-05
影响因子:
4.3
通讯作者:
中科院分区:
文献类型:
--
作者:
SARS-CoV-2 variants with enhanced transmissibility represent a serious threat to global health. Here we report machine learning models that can predict the impact of receptor-binding domain (RBD) mutations on receptor (ACE2) affinity, which is linked to infectivity, and escape from human serum antibodies, which is linked to viral neutralization. Importantly, the models predict many of the known impacts of RBD mutations in current and former Variants of Concern on receptor affinity and antibody escape as well as novel sets of mutations that strongly modulate both properties. Moreover, these models reveal key opposing impacts of RBD mutations on transmissibility, as many sets of RBD mutations predicted to increase antibody escape are also predicted to reduce receptor affinity and vice versa. These models, when used in concert, capture the complex impacts of SARS-CoV-2 mutations on properties linked to transmissibility and are expected to improve the development of next-generation vaccines and biotherapeutics. Machine learning is a powerful predictive tool that is well suited for diverse infectious disease applications. In this study, we apply machine learning to comprehensively predict the impact of mutations in the SARS-CoV-2 receptor-binding domain on both receptor affinity, which mediates viral infectivity, and escape from human serum antibodies, which mediates virus neutralization. These methods identify key mutations in current and former SARS-CoV-2 Variants of Concern, and predict novel high-risk variants that may warrant further consideration for vaccine and therapeutic development. Moreover, these models provide a valuable framework for future investigations aimed at understanding and mitigating COVID-19, especially as continued viral evolution remains a key global health threat.
登录
查看更多内容
影响因子:
16.6
作者:
Greaney AJ;Starr TN;Barnes CO;Weisblum Y;Schmidt F;Caskey M;Gaebler C;Cho A;Agudelo M;Finkin S;Wang Z;Poston D;Muecksch F;Hatziioannou T;Bieniasz PD;Robbiani DF;Nussenzweig MC;Bjorkman PJ;Bloom JD
通讯作者:
Bloom JD
影响因子:
--
作者:
Ali F;Kasry A;Amin M
通讯作者:
Amin M
影响因子:
8
作者:
Midelfort, KS;Wittrup, KD
通讯作者:
Wittrup, KD
影响因子:
17.1
作者:
Laurini E;Marson D;Aulic S;Fermeglia A;Pricl S
通讯作者:
Pricl S
影响因子:
64.5
作者:
Garcia-Beltran WF;Lam EC;St Denis K;Nitido AD;Garcia ZH;Hauser BM;Feldman J;Pavlovic MN;Gregory DJ;Poznansky MC;Sigal A;Schmidt AG;Iafrate AJ;Naranbhai V;Balazs AB
通讯作者:
Balazs AB